Just done some research on Resonance Health and excited with its potential. Rht is the old Geo2, and I believe the people who put this together have also put a number of other businesses into other shells that have eventually improved in price significantly and contributed value to shareholders. Perhaps it could happen with Rht as well!
Company structure appears pretty good with fairly tight shareholding at just over 51million shares. It has Dr Michael Woodridge as a director/chairman. Other than it Ferriscan tech, it retains its other original environmental tech but these are not of interest or as valuable as the new business. Rht will be looking at cleaning up the old businesses to concentrate on the new potential.
New tech Ferriscan is not a totally new under researched tech, definitely not an unknown. It has been through clinical trials for many years and is at the stage of commercialsiation so risk is significantly reduced. It is a tech to measure the level of iron and apparently having too much iron is fairly common and goes undiagnosed. Too much iron in the system can be fatal and affects a substantial number of people around the world- a condition known as Haemochromatosis. Having researched the disease (and checked with medical specialists and in fact I have now heard of real life case of the problem- amazing what one can come across researching companies), it is indeed a dangerous situation which can cause sever illness and premature death primarily affecting liver, heart, pancreas and pituitary glands. It is when one can confirm with real life cases and its common application that perhaps that you know that the company and tech could be a winner.
So far, test for too much iron in liver is with risk of infection and painful. Results take some time to be assessed and process cannot be applied to infants. Ferriscan tech which has been proven to work integrates with MRI (Magnetic Resonace Imaging) scan to provide results in replacement of current tech. It provides just as accurate results, cheaper and quicker results.
The market for this worldwide is certainly huge. Rht is looking initially at the UK and Aust and currently applying for authorities approval to proceed. Rht needs to link in with MRI organizations and have done so with Medtel in the UK. Through the MRI scan, Rht will then apply the tech and analyse the results that are available and present the iron concentration. It is expected that MRI results are sent through for processing by Rht and results sent back, hence protecting the tech. There is no need to have a slice of the liver to test the iron content which is currently the case- think about it if you need to be tested, a slice of your liver of MRI scan and Ferriscan analysis?
It is expected that approval will be obtained for UK and Aust in second half of calendar, with the US market to follow suit. These are all major markets and with the thec it looks like a number of markets can be tapped into very quickly, I don’t believe any heavy equipments are required- just need to link with external MRI companies and results sent through for processing. For more info look at www.resonancehealth.com and www.ferriscan.com
Summary of why Rht has big potential:
- Not at research phase, been tested to work and at short term commercialization
- Short term immediate cashflows to Rht
- Replace the existing method which is primitive, costly and painful
- Worldwide application, hard to visualize the size but can only say that it is significant
- Approvals which seems likely will each time increase its price
- Any further deals with MRI companies will each time have positive impact on Rht
- Easy process, with no expensive equipments and results processed and sent back, protecting tech
- Just did a share purchase scheme hence price depressed and expect to increase in short term
Obviously hard to calculate the potential improvement in price. Rht I feel should be looked at as a medium to longer term, say 3 to 9 months as it gets approved, deals are signed with various companies and commercialization occurs. At the moment it is at about 19c depressed (has been as high as close to 30c) due to the share purchase but green alert is suggesting that with the potential size of market worldwide, a range of 50c onwards in 3 to 9 months is not impossible.
Research yourself and see if you agree.
Bigprofit
- Forums
- ASX - By Stock
- rht- resonance health, green alert
Just done some research on Resonance Health and excited with its...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RHT (ASX) to my watchlist
|
|||||
Last
6.4¢ |
Change
0.012(23.1%) |
Mkt cap ! $28.60M |
Open | High | Low | Value | Volume |
5.5¢ | 6.5¢ | 5.5¢ | $58.48K | 971.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 6.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.4¢ | 140246 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.062 |
1 | 100000 | 0.058 |
1 | 200000 | 0.057 |
1 | 100000 | 0.056 |
1 | 103464 | 0.055 |
Price($) | Vol. | No. |
---|---|---|
0.064 | 140246 | 1 |
0.068 | 100000 | 1 |
0.069 | 65000 | 1 |
0.070 | 275189 | 3 |
0.076 | 100000 | 1 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
RHT (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online